Loopbaan van Ehab Elkhouly
Eerdere bekende functies van Ehab Elkhouly
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CANCER GENETICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2018 | 01-06-2019 |
| RESPONSE GENETICS, INC | Operationeel Directeur | - | - |
Opleiding van Ehab Elkhouly
| KasrAlAiny School of Medicine | Undergraduate Degree |
| Paul Merage School of Business | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Egypte | 2 |
| 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RESPONSE GENETICS, INC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Cancer Genetics, Inc.
 Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ. | Health Technology |
- Beurs
- Insiders
- Ehab Elkhouly
- Ervaring
